Please note, this OEL/ADE monograph also applies to pentobarbital dicalcium (CAS RN 24876-35-5) and pentobarbital sodium (CAS RN 57-33-0). Pentobarbital is a Schedule II controlled substance indicated for the short-term treatment of insomnia, an adjunct to anesthesia, to induce sedation and for emergency control of seizure. Pentobarbital sodium is a short-acting barbiturate that decreases motor activity, depresses sensory nerve action, interrupts brain functions, and promotes sedation, hypnosis and drowsiness.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Pentobarbital, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.